2010
DOI: 10.1016/s0016-5085(10)60237-5
|View full text |Cite
|
Sign up to set email alerts
|

279 Altered Gut Microbiota in Toll-Like Receptor-5 (TLR5) Deficient Mice Results in Metabolic Syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
12
0
1

Year Published

2010
2010
2021
2021

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 12 publications
(13 citation statements)
references
References 0 publications
0
12
0
1
Order By: Relevance
“…Gut microbiotas can contribute to excess host adiposity (14)(15)(16), protect against the development of type 1 diabetes (17), and induce colitis (18) and metabolic syndrome (19). Thus, the microbiota has been suggested as a target for therapeutic intervention for several chronic diseases (13,(20)(21)(22).…”
Section: Discussionmentioning
confidence: 99%
“…Gut microbiotas can contribute to excess host adiposity (14)(15)(16), protect against the development of type 1 diabetes (17), and induce colitis (18) and metabolic syndrome (19). Thus, the microbiota has been suggested as a target for therapeutic intervention for several chronic diseases (13,(20)(21)(22).…”
Section: Discussionmentioning
confidence: 99%
“…The total number of gut bacteria and/or the relative number of different species of bacteria have been found to be affected by different types of dietary interventions. These interventions also affect total and LDL cholesterol levels, fasting glucose, and insulin levels [26]. This fact also implies a possible complex role for gut microbiota in the pathogenesis of obesity and type 2 diabetes.…”
Section: Introductionmentioning
confidence: 99%
“…These mice develop features of metabolic syndrome (dyslipidemia, hypertension, insulin resistance, increased total fat) and exhibit changes in intestinal microbiota. After transferring the microbiota from TLR5 deficient mice to wild type germ-free mice, the latter exhibited some features of metabolic syndrome [26].…”
Section: Introductionmentioning
confidence: 99%
“…Neonates subjected to antibiotic therapy reportedly exhibit altered gut microbiome composition during the first weeks of life 5 , but the clinical or microbiological long-term consequences of this exposure remain unknown. Given the causal links between the intestinal microbiome and growth, obesity, and metabolic disease 6,7 , together with data from epidemiological 8,9 and experimental 10,11 studies, it has been suggested that neonatal antibiotic exposure might have an impact on growth in early life 12 . Recently, antibiotic therapy in the first week of life was reported to be associated with decreased growth during the first year of life 13 , but longer-term outcomes remain unknown.…”
mentioning
confidence: 99%